Literature DB >> 25760137

Metformin alleviates high glucose-mediated oxidative stress in rat glomerular mesangial cells by modulation of p38 mitogen-activated protein kinase expression in vitro.

Xin-Ming Yao1, Shan-Dong Ye1, Chun-Chun Xiao1, Jun-Fei Gu1, Di Yang1, Shan Wang1.   

Abstract

The aim of the current study was to investigate the effects and mechanism of metformin in oxidative stress and p38 mitogen-activated protein kinase (p38MAPK) expression in rat glomerular mesangial cells (MCs) cultured in a high glucose medium. Rat glomerular MCs (HBZY-1) were cultured in complete medium and divided into the following five groups: Normal control (NC), high glucose (HG), metformin-treated, SB203580-treated (SB) and N-acetylcysteine-treated (NAC). The production of intracellular reactive oxygen species (ROS) in rat glomerular MCs was measured using flow cytometry. Superoxide dismutase (SOD) activity and malondialdehyde (MDA) content in the supernatant was detected using colorimetric analysis and an ELISA, respectively. p22phox mRNA levels in rat glomerular MCs were determined using reverse transcription-quantitative polymerase chain reaction. The levels of p22phox protein and phosphorylated p38 mitogen-activated protein kinase (p-p38MAPK) protein in rat glomerular MCs were determined by western blot analysis. Compared with the NC group, the activity of SOD in the supernatant was significantly reduced, whereas the levels of MDA in the supernatant, intracellular p22phox mRNA and protein, p-p38MAPK protein in addition to ROS production in rat glomerular MCs were significantly increased in the HG group (P<0.05). When metformin was added to the high glucose medium, the activity of SOD in supernatant fluid was increased significantly, whereas a significant reduction (P<0.05) was observed in the levels of MDA in the supernatant, intracellular p22phox mRNA and protein, p-p38MAPK protein in addition to ROS production in rat glomerular MCs. These results were similar to those obtained when SB203580 or N-acetylcysteine was added to the high glucose medium (P<0.05). In conclusion, metformin was suggested to alleviate high glucose-induced oxidative stress and p-p38MAPK protein expression in rat glomerular MCs, which may contribute to its reno‑protective abilities in diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25760137     DOI: 10.3892/mmr.2015.3446

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  Role of Impaired Nutrient and Oxygen Deprivation Signaling and Deficient Autophagic Flux in Diabetic CKD Development: Implications for Understanding the Effects of Sodium-Glucose Cotransporter 2-Inhibitors.

Authors:  Milton Packer
Journal:  J Am Soc Nephrol       Date:  2020-04-10       Impact factor: 10.121

2.  Curcumin and metformin synergistically modulate peripheral and central immune mechanisms of pain.

Authors:  Peththa Wadu Dasuni Wasana; Chawanphat Muangnoi; Opa Vajragupta; Pranee Rojsitthisak; Pornchai Rojsitthisak; Pasarapa Towiwat
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

3.  Metformin Improves Epithelial-to-Mesenchymal Transition Induced by TGF-β1 in Renal Tubular Epithelial NRK-52E Cells via Inhibiting Egr-1.

Authors:  Meiping Guan; Wenqi Li; Lingling Xu; Yanmei Zeng; Dan Wang; Zongji Zheng; Fuping Lyv; Yaoming Xue
Journal:  J Diabetes Res       Date:  2018-06-27       Impact factor: 4.011

4.  XBP1 inhibits mesangial cell apoptosis in response to oxidative stress via the PTEN/AKT pathway in diabetic nephropathy.

Authors:  Yan Wang; Zhong He; Qiu Yang; Guangju Zhou
Journal:  FEBS Open Bio       Date:  2019-06-02       Impact factor: 2.693

Review 5.  Metformin: the updated protective property in kidney disease.

Authors:  Qingjun Pan; Xing Lu; Chunfei Zhao; Shuzhen Liao; Xiaoqun Chen; Fengbiao Guo; Chen Yang; Hua-Feng Liu
Journal:  Aging (Albany NY)       Date:  2020-05-01       Impact factor: 5.682

Review 6.  Accelerated Kidney Aging in Diabetes Mellitus.

Authors:  Jing Guo; Hui Juan Zheng; Wenting Zhang; Wenjiao Lou; Chenhui Xia; Xue Ting Han; Wei Jun Huang; Fan Zhang; Yaoxian Wang; Wei Jing Liu
Journal:  Oxid Med Cell Longev       Date:  2020-07-27       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.